Devil's Claw (Harpagophytum procumbens)
What Is Devil's Claw?
Devil's Claw is the common name for Harpagophytum procumbens, a plant of the Pedaliaceae family, native to the Kalahari of southern Africa. The material in circulation is tuber (secondary storage root) — an underground part, harvested once the plant has drawn its reserves down. Devil's Claw is the name in everyday use, while Harpagophytum procumbens is the name that identifies it unambiguously across languages, trade documents and safety literature. Its character is described as extremely bitter, earthy, which is often how the raw material is checked for quality.
In African traditional medicine, Devil's Claw is a long-standing entry. Its use is carried largely through oral transmission among traditional healers, and it entered the written record comparatively late, through colonial-era botanical surveys and modern ethnobotanical fieldwork. Beyond its practical use it carries cultural associations — named for its claw-shaped fruit hooks — symbolizes tenacity and used in Southern African traditional medicine (San, Khoi peoples).
Today most searches for Devil's Claw come from people reading about fever, appetite, pain relief and joint health, or checking how it sits alongside a medication they already take. The use most often documented in the literature is anti-inflammatory for osteoarthritis and low back pain, followed by analgesic (harpagoside inhibits COX-2, iNOS).
How Does Devil's Claw Work?
Devil's Claw works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in tuber (secondary storage root) rather than by one marker molecule.
African traditional practice situates a plant within community, season and preparation ritual as much as within its chemistry. That older description was arrived at without chemistry, and it does not map neatly onto constituent names — but it records centuries of observation about dose, preparation and who the plant suited.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 3 sources. Reported findings centre on cochrane review identified moderate evidence for low back pain (60mg harpagoside/day noninferior to rofecoxib 12.5mg). Where research exists, it examines anti-inflammatory for osteoarthritis and low back pain, analgesic (harpagoside inhibits COX-2, iNOS) and may improve appetite and dyspeptic symptoms. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
Devil's Claw is studied as a whole preparation because isolating one fraction tends to behave differently from the material it was taken out of — a recurring finding across the plant-chemistry literature.
Because these constituents are processed by the same pathways that handle many medicines, Devil's Claw is documented as interacting with warfarin / anticoagulants, nsaids and antihypertensives. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Devil's Claw can differ substantially; this is why reference entries specify tuber (secondary storage root) and, where they exist, standardisation markers.